Skip to main content

Evnin Luke's Form 4 filing

Werewolf Therapeutics, Inc. (HOWL) · filed Apr 30, 2025

Accession no.
0001415889-25-011570
Filed
Apr 30, 2025, 4:09 PM ET
Trade date
Mar 27, 2025
Filing delay
34 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 2 non-derivative transactions and 2 derivative transactions. Open-market sales total $2.55K. It was filed 34 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Evnin LukeCIK 0001134657Director, 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 27, 2025Common StockXIn-the-money exerciseAcquired+28,113$0.09+$2,530.174,312,285Indirect
Mar 27, 2025Common StockSSaleDisposed−2,425$1.05−$2,546.254,309,860Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 27, 2025Common StockXIn-the-money exerciseDisposed−4,015$0.00$00Indirect
Mar 27, 2025Common StockXIn-the-money exerciseDisposed−24,098$0.00$00Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)